Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (67)

2024

  1. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial

    The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 802-810

  2. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

  3. Dispersal history of SARS-CoV-2 in Galicia, Spain

    Journal of Medical Virology, Vol. 96, Núm. 7

  4. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 777-787

  5. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola, Vol. 102, Núm. 7, pp. 355-363

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  3. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  4. Dupilumab in children and adolescents with atopic dermatitis: A case series and literature review

    Piel, Vol. 38, Núm. 4, pp. 231-239

  5. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  6. Epidemiología de la miastenia grave en la península ibérica y Latinoamérica

    Revista de neurologia, Vol. 76, Núm. 2, pp. 59-68

  7. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

  8. GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 1, pp. 29-38

  9. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group

    Parkinson's Disease, Vol. 2023

  10. Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints

    Journal of Clinical Neurology (Korea), Vol. 19, Núm. 4, pp. 344-357

  11. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

    PLoS Medicine, Vol. 20, Núm. 10

  12. Suicidal ideation among people with Parkinson's disease and comparison with a control group

    International journal of geriatric psychiatry, Vol. 38, Núm. 5, pp. e5919

  13. The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912

2022

  1. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 4, pp. 1020-1028

  2. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273